| 06/16 | ALEMBIC PHARMACEUTICALS : JV Gets US FDA Nod for Testosterone Topical Solution | MT |
| 06/15 | ELI LILLY AND : JPMorgan Adjusts Price Target on Eli Lilly to $260 From $240, M.. | MT |
| 06/15 | ELI LILLY AND : to Compare Migraine Drugs Emgality, Nurtec ODT in Phase 4 Study | MT |
| 06/15 | AstraZeneca antibody cocktail fails to prevent COVID-19 in large trial | RE |
| 06/14 | ELI LILLY AND : Significant Insider Selling Continues at Eli Lilly (LLY) | MT |
| 06/14 | ELI LILLY AND : Lilly to Participate in Guggenheim Biopharma Strategy Series | PR |
| 06/14 | ELI LILLY AND : Bernstein Adjusts Price Target on Eli Lilly to $250 From $205, .. | MT |
| 06/14 | ELI LILLY AND : Goldman Sachs Adjusts Eli Lilly's Price Target to $270 From $25.. | MT |
| 06/14 | Fiserv Appoints Wafaa Mamilli to Board of Directors | AQ |
| 06/11 | ELI LILLY AND : Significant Insider Selling in Shares of Eli Lilly (LLY) Contin.. | MT |
| 06/11 | INSIDER TRENDS : Insider Sales Continue 90-Day Trend at Eli Lilly | MT |
| 06/11 | ELI LILLY AND : Thinking about trading options or stock in Crispr Therapeutics,.. | PR |
| 06/11 | MARKET CHATTER : Eli Lilly Says Internal Inquiry Shows No Wrongdoings in Stateme.. | MT |
| 06/10 | INSIDER TRENDS : Insider Prolongs Selling Trend at Eli Lilly | MT |
| 06/10 | MARKET CHATTER : Eli Lilly Reportedly Says Internal Inquiry Shows Company Did No.. | MT |
| 06/10 | STREET COLOR : Eli Lilly Memo States Company Did Not Make False Statements to FD.. | MT |
| 06/10 | ALX ONCOLOGY : to Collaborate With Lilly on Combination Therapy for Gastric Can.. | MT |
| 06/10 | ALX Oncology, Eli Lilly to Evaluate Gastric Cancer Treatment | DJ |
| 06/09 | ELI LILLY AND : Insider Selling in Eli Lilly (LLY) Shares Continues | MT |
| 06/08 | INSIDER TRENDS : Insider Prolongs 90-Day Selling Trend at Eli Lilly | MT |
| 06/07 | U.S. approval of Biogen Alzheimer's drug sends shares soaring, hailed as 'big.. | RE |
| 06/07 | US Stocks Mixed Monday as Dow Slips, Nasdaq Rises | MT |
| 06/07 | CLOSE UPDATE : US Stocks Start Week Mostly Lower as Investors Continue to Weigh .. | MT |
| 06/07 | ELI LILLY AND : Lilly Shares Jump 12% Following FDA Approval of Biogen, Esai Al.. | MT |
| 06/07 | Lilly Up Over 14%, on Track for Record High Close -- Data Talk | DJ |
| 06/07 | Shares Slip in Midday Trading With DJIA, S&P in Red; Nasdaq Holds Slight Gain | MT |
| 06/07 | MIDDAY REPORT : US Stocks Slip in Midday Trading With S&P, Dow Red; Nasdaq Holds.. | MT |
| 06/04 | Investors, patients await FDA decision on Biogen Alzheimer's drug due Monday | RE |
| 06/03 | ELI LILLY AND : Lilly to Participate in Goldman Sachs Healthcare Conference | PR |
| 06/03 | ELI LILLY AND : Innovent Biologics' Lung Cancer Therapy Gets Chinese Approval | MT |
| 06/02 | ELI LILLY AND : Late-Stage Data Show Treatment With Taltz Improves Inflammatory.. | MT |
| 06/02 | ELI LILLY AND : Olumiant Drug May Improve Rheumatoid Arthritis Symptoms, Late-S.. | MT |
| 06/01 | ELI LILLY AND : Taltz® Showed Consistent, Long-Term Improvement in Key Signs an.. | PR |
| 06/01 | ELI LILLY AND : Lands Emergency Use Approval For COVID-19 Antibody Drugs In Ind.. | MT |
| 06/01 | Eli Lilly gets Indian emergency use nod for COVID-19 antibody drug combinatio.. | RE |
| 05/28 | DICERNA PHARMACEUTICALS : Announces FDA Acceptance of Lilly's Investigational N.. | AQ |
| 05/28 | MARKET CHATTER : Eli Lilly Faces US Criminal Inquiry Into Alleged Irregularities.. | MT |
| 05/27 | ELI LILLY AND : Receives Subpoena from US Justice Department over New Jersey Fa.. | MT |
| 05/27 | U.s. justice department opens criminal probe of eli lilly and co over drug ma.. | RE |
| 05/27 | DICERNA PHARMACEUTICALS : Says Partner Eli Lilly's Investigational New Drug App.. | MT |
| 05/27 | ELI LILLY AND : Receives Subpoena From US Department of Justice Over Manufactur.. | MT |
| 05/26 | ELI LILLY AND : Insider at Eli Lilly (LLY) Makes Significant Sale of Stock | MT |
| 05/26 | Covid-19 Treatment From Vir, GlaxoSmithKline Is Approved -- Update | DJ |
| 05/26 | Covid-19 Treatment From Vir, GlaxoSmithKline Is Approved | DJ |
| 05/25 | ELI LILLY AND : (LLY) sees Significant Insider Selling Continuing | MT |
| 05/25 | INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Eli Lilly | MT |
| 05/24 | ELI LILLY AND : Insider Selling in Eli Lilly (LLY) Shares Continues | MT |
| 05/24 | INSIDER TRENDS : 90-Day Insider Selling Trend Prolonged at Eli Lilly | MT |
| 05/24 | ELI LILLY AND : Says Mirikizumab Improved Fatigue in Crohn's Disease Patients i.. | MT |
| 05/23 | ELI LILLY AND : to Supply Switzerland with Doses of COVID-19 Monoclonal Antibod.. | MT |
| 05/22 | ELI LILLY AND : Mirikizumab Improves Fatigue in Patients with Crohn's Disease i.. | PR |
| 05/21 | INSIDER TRENDS : Insider 90-Day Selling Trend Extended at Eli Lilly | MT |
| 05/21 | EU regulator backs use of GSK-Vir antibody to treat COVID-19 | RE |
| 05/20 | ELI LILLY AND : Lilly Says Diabetes Drug Tirzepatide Met All Primary, Key Secon.. | MT |
| 05/20 | Eli Lilly's Tirzepatide Meets Key Endpoints in Longest Phase 3 Study | DJ |
| 05/19 | ACACIA PHARMA : Appoints Lilly Official as New Chief Commercial Officer | MT |
| 05/18 | Correction to FDA Accepts Innovent, Eli Lilly Application Article | DJ |
| 05/18 | ELI LILLY AND : Innovent Say FDA Accepts BLA Filing for Sintilimab in Nonsquamo.. | MT |
| 05/18 | FDA Accepts Innovent, Eli Lilly Application for Sintilimab | DJ |
| 05/18 | ELI LILLY AND : U.S. FDA Accepts Regulatory Submission for Sintilimab in Combin.. | PR |
| 05/17 | NATCO PHARMA : Seals Licensing Deal for COVID-19 Treatment Drug | MT |
| 05/16 | Companies Ponder Speeding Up Plans to Bring Workers Back to Offices -- Update | DJ |
| 05/16 | Companies Ponder Speeding Up Plans to Bring Workers Back to Offices | DJ |
| 05/13 | Samsung BioLogics says decision pending on making Moderna vaccine as report i.. | RE |
| 05/13 | TORRENT PHARMACEUTICALS : Signs Licensing Agreement with Eli Lilly for COVID-19.. | MT |
| 05/13 | ELI LILLY AND : Lilly to Participate in UBS Global Healthcare Virtual Conferenc.. | PR |
| 05/13 | Push for Covid-19 Vaccine Patent Waiver Isn't a Panacea - but It Could Nudge .. | AQ |
| 05/13 | ELI LILLY AND COMPANY : Ex-dividend day for | FA |
| 05/11 | ELI LILLY AND : MiNA Therapeutics Launch Research Collaboration | MT |
| 05/11 | ELI LILLY AND : Lilly Starts Global Research Collaboration With MiNA Therapeuti.. | MT |
| 05/11 | ELI LILLY AND : Lilly and MiNA Therapeutics Announce saRNA Research Collaborati.. | PR |
| 05/11 | Eli Lilly, MiNA Therapeutics Join in Research Collaboration | DJ |
| 05/10 | ELI LILLY AND : UBS Adjusts Eli Lilly's Price Target to $193 From $170, Modelin.. | MT |
| 05/10 | Today on Wall Street: Bad news is good news | |
| 05/10 | Indian shares settle up as record high commodity prices lift metal stocks | RE |
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
